Phrontline Biopharma is a biotechnology company dedicated to the research and development of next-generation ADCs. Founded in 2022 by a team of seasoned industry veterans with deep and complementary experience in ADC drug discovery and development, Phrontline has built a globally competitive platform for bispecific and dual-payload ADCs. The company has established a robust pipeline of innovative candidates spanning preclinical to early clinical stages and is committed to advancing a new paradigm in precision oncology through scientific innovation and to bringing transformative therapies to patients worldwide.
Leadership & Board
Current Number of Employees10
Current LinkedIn Followers293
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$120M
Total Amount Raised$120M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$60M
Latest Funding Amount$60M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Phrontline Biopharma had 10 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
10Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Phrontline Biopharma had 293 followers as of September 28, 2026. The number of followers increased by 1 (0.34%) week-over-week.
293Latest Followers Count
1(0.34%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.